In this instalment of our Toolbox blog series, we take a closer look at mipomersen (Kynamro®) – the first gapmer therapeutic approved by the FDA.| blog.biosearchtech.com
Has the next generation of treatments arrived? Circular RNA (circRNA) holds huge potential for emerging pharmaceutical applications, read on to learn more.| blog.biosearchtech.com
Oligo therapeutics have improved, with 18 therapies approved in 2023; more in late-stage development. ASO and siRNA are promising technologies. Learn more| blog.biosearchtech.com